NI709560ACTIVE
Incorporated: 2024-02-01
SIC: 72110
Last updated: 31 Mar 2026
Antigenesis Biologics develops a therapeutic antibody discovery platform that uses peptide‑mRNA nano Sign up to read more
| Allotment | Filed | Share Class | Round Size | Round Type |
|---|---|---|---|---|
2026-03-31 | £120k |
Companies with the most similar business descriptions.